Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors

Clinical trial NCT00049088 · TERMINATED

Trial details

NCT number: NCT00049088
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2002-08-01
Primary completion: 2009-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.